FORT MYERS — Cancer-testing firm NeoGenomics reported a profit for the quarter ending March 31 after revenues surged 72% compared with the same quarter one year ago.
Continue reading your article with a Business Observer subscription.
What's included:
✓ Unlimited digital access to BusinessObserverFL.com
✓ E-Newspaper app, digital replica of print edition